Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Norihisa, Ohtake"'
Autor:
Mari Uomoto, Yukihide Ota, Yukio Suzuki, Asuna Yumori, Hiroto Narimatsu, Shiro Koizume, Shinya Sato, Yoshiyasu Nakamura, Shohei Myoba, Norihisa Ohtake, Haruya Saji, Etsuko Miyagi, Yohei Miyagi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Endometrial cancer is the most common gynecological malignancy; however, there is no useful blood diagnostic biomarker. This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2), a biomarker of ovarian
Externí odkaz:
https://doaj.org/article/0b972ce8dada4faabcf3ff7c7faa693b
Autor:
Atsushi Goto, Kei Miyakawa, Izumi Nakayama, Susumu Yagome, Juan Xu, Makoto Kaneko, Norihisa Ohtake, Hideaki Kato, Akihide Ryo
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
ObjectiveDespite extensive vaccination campaigns to combat the coronavirus disease (COVID-19) pandemic, variants of concern, particularly the Omicron variant (B.1.1.529 or BA.1), may escape the antibodies elicited by vaccination against SARS-CoV-2. T
Externí odkaz:
https://doaj.org/article/c694ad8716c041e1850a90c226734932
Autor:
Atsushi Goto, Hirofumi Go, Kei Miyakawa, Yutaro Yamaoka, Norihisa Ohtake, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Takahiro Mihara, Kotaro Senuki, Tomoyuki Miyazaki, Satoshi Ikeda, Takashi Ogura, Hideaki Kato, Ikuro Matsuba, Naoko Sanno, Masaaki Miyakawa, Haruo Ozaki, Masakazu Kikuoka, Yasuo Ohashi, Akihide Ryo, Takeharu Yamanaka
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Objective: There is scarce evidence regarding the long-term persistence of neutralizing antibodies among coronavirus disease 2019 (COVID-19) survivors. This study determined neutralizing antibody titers (NT50) and antibodies against spike protein (SP
Externí odkaz:
https://doaj.org/article/ce74df3f08c1470ba28b127ff7579ae5
Autor:
Sousuke Kubo, Norihisa Ohtake, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Yutaro Yamaoka, Kota Murohashi, Eri Hagiwara, Takahiro Mihara, Atsushi Goto, Etsuko Yamazaki, Takashi Ogura, Takeshi Kaneko, Takeharu Yamanaka, Akihide Ryo
Publikováno v:
Frontiers in Microbiology, Vol 11 (2021)
ObjectivesSerological tests for COVID-19 have been instrumental in studying the epidemiology of the disease. However, the performance of the currently available tests is plagued by the problem of variability. We have developed a high-throughput serol
Externí odkaz:
https://doaj.org/article/7dc44a0a2035415fa7dde6a60ab4663a
Publikováno v:
The Journal of Infectious Diseases. 227:221-225
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised concerns regarding vaccine effectiveness. We investigated humoral and cellular immune responses against SARS-CoV-2 in healthcare workers before and after a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fab7de47aef316f8fd0b93ab6035954
https://doi.org/10.1093/infdis/jiac344
https://doi.org/10.1093/infdis/jiac344
Autor:
Hideaki, Kato, Kei, Miyakawa, Norihisa, Ohtake, Yutaro, Yamaoka, Satoshi, Yajima, Etsuko, Yamazaki, Tomoko, Shimada, Atsushi, Goto, Hideaki, Nakajima, Akihide, Ryo
Publikováno v:
Vaccine. 40:2652-2655
To evaluate vaccine-induced humoral and cell-mediated immunity at 6 months after completion of two doses of BNT162b2 vaccination, immunoglobulin G against SARS-CoV-2 spike protein (SP IgG), 50% neutralizing antibody (NT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d38946f7e997d598ea34bfeb73e0ea
https://doi.org/10.1016/j.vaccine.2022.03.057
https://doi.org/10.1016/j.vaccine.2022.03.057
Autor:
Kei, Miyakawa, Hideaki, Kato, Norihisa, Ohtake, Sundararaj, Stanleyraj Jeremiah, Akihide, Ryo
Publikováno v:
The Journal of infectious diseases.
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised concerns regarding vaccine effectiveness. We investigated humoral and cellular immune responses against SARS-CoV-2 in healthcare workers before and after a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e468eb175b66c033e7cb9c6d9afaca3d
https://pubmed.ncbi.nlm.nih.gov/35978486
https://pubmed.ncbi.nlm.nih.gov/35978486
Autor:
Noriaki Arakawa, Hiroshi Kobayashi, Naohiro Yonemoto, Yusuke Masuishi, Yoko Ino, Hiroshi Shigetomi, Naoto Furukawa, Norihisa Ohtake, Yohei Miyagi, Fumiki Hirahara, Hisashi Hirano, Etsuko Miyagi
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165609 (2016)
BACKGROUND:There is currently no reliable serum biomarker for ovarian clear cell carcinoma (CCC), a highly lethal histological subtype of epithelial ovarian cancer (EOC). Previously, using a proteome-based approach, we identified tissue factor pathwa
Externí odkaz:
https://doaj.org/article/bfce245f82d04b2db77e158a978fb8bd
Autor:
Atsushi Goto, Kei Miyakawa, Izumi Nakayama, Susumu Yagome, Juan Xu, Makoto Kaneko, Norihisa Ohtake, Hideaki Kato, Akihide Ryo
BackgroundLittle is known about the population prevalence of antibodies against emerging immune escape variants of SARS-CoV-2.MethodsA population-based prevalence study was conducted in Yokohama City, the most populous municipality of Japan. Quantita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2770cfd63431025d1b6d4e32a1e93292
https://doi.org/10.1101/2022.03.26.22272766
https://doi.org/10.1101/2022.03.26.22272766
Autor:
Kei Miyakawa, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Hirofumi Go, Yutaro Yamaoka, Norihisa Ohtake, Hideaki Kato, Satoshi Ikeda, Takahiro Mihara, Ikuro Matsuba, Naoko Sanno, Masaaki Miyakawa, Masaharu Shinkai, Tomoyuki Miyazaki, Takashi Ogura, Shuichi Ito, Takeshi Kaneko, Kouji Yamamoto, Atsushi Goto, Akihide Ryo
Publikováno v:
Open Forum Infectious Diseases
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits varying degrees of protective immunity conferred by neutralizing antibodies (nAbs). In this study, we report the persistence of nAb responses over 12 months aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8522dfcfae4c7e7a52b59f239b2675e8
http://europepmc.org/articles/PMC8689844
http://europepmc.org/articles/PMC8689844